Search Results 111-120 of 15462 for hla genotype

  1. Publications - Andrew J. Bentall, M.B., Ch.B., M.D. - Mayo Clinic

    Chronic Histologic Changes Are Present Regardless of HLA Mismatches: Evidence from HLA-Identical Living Donor Kidney Transplants. Transplantation. 2021 Nov ...

  2. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

    Participation eligibility · Chronic Hepatitis C virus infection · Screening laboratory result indicating Hepatitis C virus genotype 3 infection · Must be new to ...

  3. Neurology - Clinical trials - Mayo Clinic

    ... genotype, including understudied APOE2 and APOE4 homozygotes (HMs) at the lowest and highest risk and those APOE4 HMs and heterozygotes (HTs) who remain ...

  4. A Study of Gluten Intolerance in Patients with Diarrhea Predominant Irritable Bowel Syndrome - Mayo Clinic

    ... HLA-DQ2 positive. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  5. Measles - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    Translating the discovery of immunogenic measles peptides into a candidate vaccine. The Vaccine Research Group has identified 13 naturally processed HLA-DRB1*03 ...

  6. A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor - Mayo Clinic

    About this study. This is a Phase II, open-label, two strata, multicenter, prospective study of plerixafor-mobilized HLA-identical sibling allografts in ...

  7. Publications - Francisco Alvarez, M.D. - Mayo Clinic

    ... HLA antibodies. J Heart Lung Transplant. 2024 Apr; 43 (4):663-672 Epub 2023 Dec 21. View PubMed; Shah SZ, Alvarez FG, Sanghavi DK, Moreno Franco P, Isha S ...

  8. Clinical trials - Oncology (Medical)

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

  9. A Study to Establish a Rare Diseases Registry for Niemann-Pick Disease Types A, B and C - Mayo Clinic

    ... genotype-phenotype correlations; and to support post marketing obligations for approved therapies. Participation eligibility. Participant eligibility ...

  10. Publications - Leigh G. Griffiths, Ph.D., MRCVS - Mayo Clinic

    Publications. Print. Panicker AJ, Prokop LJ, Hacke K, Jaramillo A, Griffiths LG. Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A ...